2N is an industry-leader in access control systems including audiovisual IP intercoms, IP answering units and IP access control units. 2N IP solutions are compatible with third-party systems for easy integration. 2N was stablished in 1991 in the Czech Republic with headquarters in Prague. Since January 2018, 2N and Axis Communications have joined forces. Axis Communications distributes and supports 2N products in the Americas and Asia Pacific (excluding Japan). 1-800-444-2947 www.axis.com www.2n.com
2Pi
2Pi develop advanced metasurface flat optics technology. We pioneer a new class of optical components and solutions with unprecedented performance, ultra-compactness, and light-weight for use in consumer electronics, industry automation, automotive and beyond. | Born from MIT’s Top-10 research, 2Pi pioneers high-performance metasurface technology. Through 12″ foundry partnerships, we deliver wafer-level, imaging-grade optics designed to revolutionize optical interconnects, display, and sensing. We bridge the gap between breakthrough meta-optics and mass-scale integration for next-gen communication systems.
24M Technologies, Inc.
24M Technologies is revolutionizing how the world makes batteries by addressing critical safety, cost, and performance barriers to widespread EV adoption. The company is accelerating the transition to a cleaner, electrified future through four groundbreaking innovations: Impervio, a transformative separator technology that prevents catastrophic battery fires; Eternalyte, a proprietary liquid electrolyte formula that enables over 1,600km battery range, rapid charging and unparalleled low temperature performance; 24M ETOP, a revolutionary pack design that maximises energy density; and LiForever, a chemistry-agnostic semisolid electrode that lowers costs and makes up to 90% of a battery’s material recyclable. Working with leading industry companies worldwide, it combines decades of battery expertise with out-of-the-box thinking to develop safer, longer lasting, and more affordable battery solutions that meet the world’s growing energy demands.
20/20 Onsite
20/20 Onsite is a specialty vendor for sponsors and CROs conducting clinical trials with ocular endpoints, providing end-to-end ophthalmic trial consultation, clinical field execution, and ongoing support. Through a single-call accountability model, 20/20 Onsite helps sponsors de-risk ocular endpoint complexity and increase the likelihood of on-time, on-budget, protocol-adherent trial success. Its proprietary point-of-need service delivery model reaches participants where they live, work, or congregate, reducing patient burden, improving retention, and supporting diverse enrollment strategies. Backed by proven expertise, nationwide experience at scale, and validated regulatory rigor, 20/20 Onsite has supported more than 45 clinical trials, served over 100,000 patients, and consistently delivered Net Promoter Scores above 95. To learn more about how 20/20 Onsite delivers single-call ophthalmic execution for trials with ocular endpoints, visit www.2020onsite.com.